LNAI

Lunai Bioworks, Inc. integrates artificial intelligence, phenomics, and living biological systems to advance drug discovery and development. The company focuses on decoding disease biology to create clinically relevant therapies, utilizing its AI platform to identify therapeutic targets and biomarkers. Its operations span oncology, neurology, and biosecurity, employing in vivo modeling with zebrafish to assess treatment efficacy and safety. Lunai collaborates with pharmaceutical partners to enhance precision medicine through validated and integrated approaches to drug development.